The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 31, 2009
Filed:
Aug. 16, 2006
Yongqi Deng, Newton, MA (US);
Patrick J. Curran, Winthrop, MA (US);
Gerald W. Shipps, Jr., Stoneham, MA (US);
Lianyun Zhao, Burlington, MA (US);
M. Arshad Siddiqui, Newton, MA (US);
Janeta Popovici-muller, Waltham, MA (US);
Jose S. Duca, Cranford, NJ (US);
Alan W. Hruza, Hackettstown, NJ (US);
Thierry O. Fischmann, Scotch Plains, NJ (US);
Vincent S. Madison, Mountain Lakes, NJ (US);
Rumin Zhang, Edison, NJ (US);
Charles W. Mcnemar, High Bridge, NJ (US);
Todd W. Mayhood, Randolph, NJ (US);
William T. Windsor, East Brunswick, NJ (US);
Emma M. Lees, Oakland, CA (US);
David A. Parry, Mountain View, CA (US);
Yongqi Deng, Newton, MA (US);
Patrick J. Curran, Winthrop, MA (US);
Gerald W. Shipps, Jr., Stoneham, MA (US);
Lianyun Zhao, Burlington, MA (US);
M. Arshad Siddiqui, Newton, MA (US);
Janeta Popovici-Muller, Waltham, MA (US);
Jose S. Duca, Cranford, NJ (US);
Alan W. Hruza, Hackettstown, NJ (US);
Thierry O. Fischmann, Scotch Plains, NJ (US);
Vincent S. Madison, Mountain Lakes, NJ (US);
Rumin Zhang, Edison, NJ (US);
Charles W. McNemar, High Bridge, NJ (US);
Todd W. Mayhood, Randolph, NJ (US);
William T. Windsor, East Brunswick, NJ (US);
Emma M. Lees, Oakland, CA (US);
David A. Parry, Mountain View, CA (US);
Schering Corporation, Kenilworth, NJ (US);
Abstract
Quinoline-based inhibitors of cyclin dependent kinase 2, compositions including the inhibitors, and methods of using the inhibitors and inhibitor compositions are described. The inhibitors and compositions including them are useful for treating disease or disease symptoms. The invention also provides for methods of making CDK-2 inhibitor compounds, methods of inhibiting CDK-2, and methods for treating disease or disease symptoms.